On Wednesday, April 14, 2021, Director Jeremiah B. Frueauf will speak during the session "Adapting Your IP Strategy to New Challenges in the 2020s" Pharma & Biotech IP Connect, hosted by IAM. This session seeks to identify the most significant changes on the horizon and explore how these will impact approaches to protecting and exploiting healthcare innovations. Whether it’s the after-effects of the pandemic, the creation of a unified patent system in Europe or new legal questions arising from cutting-edge developments in biotechnology, a number of dramatic developments will confront life sciences IP strategists in the coming years.
- Determining which new factors are challenging traditional IP strategy
- Addressing the UPC and other impending political change
- Predicting the key strategic developments for the next decade